Skip to content
MedsAcross

Medicine

Hydrochlorothiazide and Metoprolol 50 mg/100 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Hydrochlorothiazide and Metoprolol 50 mg/100 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)…

Key facts

Active ingredient (INN)
Hydrochlorothiazide and Metoprolol
Brand
Sold under the generic name
Strength
50 mg/100 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets, 500 tablets and 8 more
Manufacturers
Alembic PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaMylan Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
20 August 2004
Identifiers
RxCUI 866479, 866482, 866491DailyMed set ID 2b77f66f-6891-4977-be8f-7955473d2f92, b6cf0f43-8dc3-4535-b651-daf1f9e0336c, 538ea34a-1ac3-48c8-b841-43be09285e12 +1NDC 62332-117, 0378-0445, 46708-117 +1Application ANDA202870, ANDA076792, ANDA090654

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle46708-117-10Alembic PharmaceuticalsIndia17 September 2013
30 tablet in 1 bottle46708-117-30Alembic PharmaceuticalsIndia17 September 2013
500 tablet in 1 bottle46708-117-50Alembic PharmaceuticalsIndia17 September 2013
30 tablet in 1 bottle62332-117-30Alembic PharmaceuticalsIndia15 October 2015
100 tablet in 1 bottle62332-117-31Alembic PharmaceuticalsIndia15 October 2015
500 tablet in 1 bottle62332-117-71Alembic PharmaceuticalsIndia15 October 2015
100 tablet in 1 bottle62756-369-08Sun Pharmaceutical IndustriesIndia1 April 2022
1000 tablet in 1 bottle62756-369-18Sun Pharmaceutical IndustriesIndia1 April 2022
30 tablet in 1 bottle62756-369-83Sun Pharmaceutical IndustriesIndia1 April 2022
100 tablet in 1 bottle62756-369-88Sun Pharmaceutical IndustriesIndia1 April 2022
100 tablet in 1 bottle, plastic0378-0445-01Mylan Pharmaceuticals20 August 2004

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Hydrochlorothiazide and Metoprolol

Clinical summary

Hydrochlorothiazide and Metoprolol is a fixed-dose combination of a thiazide diuretic and a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. MedsAcross supplies Hydrochlorothiazide and Metoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydrochlorothiazide and Metoprolol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hydrochlorothiazide and Metoprolol 50 mg/100 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.